Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate improvement and efficacy of paliperidone
extended-release for subjective well-being and drug attitudes of participants, when switching
from oral antipsychotics in participants with schizophrenia (psychiatric disorder with
symptoms of emotional instability, detachment from reality, often with delusions and
hallucinations, and withdrawal into the self).